tiprankstipranks
Advertisement
Advertisement

SPRO Stock Latest News

Spero Therapeutics Earnings Call Signals High‑Risk Pivot
Company AnnouncementsSpero Therapeutics Earnings Call Signals High‑Risk Pivot
10d ago
SPRO
Spero Therapeutics appoints Debra Jeske Zack as chief medical officer
PremiumThe Fly
Spero Therapeutics appoints Debra Jeske Zack as chief medical officer
28d ago
XGN
SPRO
Spero Therapeutics inks major CD40L and royalty deals
PremiumCompany Announcements
Spero Therapeutics inks major CD40L and royalty deals
1M ago
8K
SPRO
Spero Therapeutics secures $105M non-dilutive financing to develop SP001
PremiumThe Fly
Spero Therapeutics secures $105M non-dilutive financing to develop SP001
1M ago
SPRO
Spero Therapeutics, Innovent Biologics enter license agreement for SP001
PremiumThe Fly
Spero Therapeutics, Innovent Biologics enter license agreement for SP001
1M ago
SPRO
Spero Therapeutics, Innovent Biologics announce exclusive IBI355 license pact
PremiumThe FlySpero Therapeutics, Innovent Biologics announce exclusive IBI355 license pact
1M ago
SPRO
Spero Therapeutics Expands Stock Incentive Plan and Authorization
Premium
Company Announcements
Spero Therapeutics Expands Stock Incentive Plan and Authorization
2M ago
8K
SPRO
Spero Therapeutics secures FDA approval for Utebzi
Premium
Company Announcements
Spero Therapeutics secures FDA approval for Utebzi
2M ago
8K
SPRO
GSK, Spero Therapeutics announce FDA approval of Utebzi
PremiumThe Fly
GSK, Spero Therapeutics announce FDA approval of Utebzi
2M ago
GSK
SPRO
Spero Therapeutics Co-Founder Resigns From Board Roles
PremiumCompany Announcements
Spero Therapeutics Co-Founder Resigns From Board Roles
7M ago
8K
SPRO
GSK Resubmits NDA, Triggering Milestone for Spero Therapeutics
PremiumCompany Announcements
GSK Resubmits NDA, Triggering Milestone for Spero Therapeutics
8M ago
8K
SPRO
Spero announces GSK filed NDA resubmission to FDA for tebipenem HBr
PremiumThe Fly
Spero announces GSK filed NDA resubmission to FDA for tebipenem HBr
8M ago
GSK
SPRO
Spero Therapeutics announces inducement grant under Nasdaq listing rule
PremiumThe FlySpero Therapeutics announces inducement grant under Nasdaq listing rule
9M ago
SPRO
Spero Therapeutics Focuses on Tebipenem HBr Program
Premium
Company Announcements
Spero Therapeutics Focuses on Tebipenem HBr Program
9M ago
SPRO
Spero Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
Spero Therapeutics Reports Q3 2025 Financial Results
9M ago
8K
SPRO
Spero Therapeutics, GSK announce PIVOT-PO trial efficacy and safety results
PremiumThe Fly
Spero Therapeutics, GSK announce PIVOT-PO trial efficacy and safety results
10M ago
GSK
SPRO
Spero Therapeutics’ Positive Earnings Call Highlights
PremiumCompany Announcements
Spero Therapeutics’ Positive Earnings Call Highlights
1y ago
SPRO
Spero Therapeutics Reports Q2 2025 Results and Trial Success
PremiumCompany Announcements
Spero Therapeutics Reports Q2 2025 Results and Trial Success
1y ago
SPRO
Spero Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Spero Therapeutics Reports Q2 2025 Financial Results
1y ago
8K
SPRO
GSK and Spero Therapeutics Complete Promising Phase 3 Study on Oral Antibiotic for cUTI
PremiumCompany AnnouncementsGSK and Spero Therapeutics Complete Promising Phase 3 Study on Oral Antibiotic for cUTI
1y ago
GSK
SPRO
GSK and Spero Therapeutics: Phase 3 Study Completion on Oral vs. IV UTI Treatment
Premium
Company Announcements
GSK and Spero Therapeutics: Phase 3 Study Completion on Oral vs. IV UTI Treatment
1y ago
GSK
SPRO
Spero Therapeutics Increases Stock Incentive Plan Shares
Premium
Company Announcements
Spero Therapeutics Increases Stock Incentive Plan Shares
1y ago
8K
SPRO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >